Global Vascular Imaging Systems Market by Product (CT, MRI, X-ray, Ultrasound and nuclear imaging), By Application (cardiology, oncology, neurology and others), By End User (Hospitals, Specialty clinics and Diagnostic centres); Size, Share, Development, Growth and Demand Forecast, 2018-2024.

Global Vascular Imaging Systems Market by Product (CT, MRI, X-ray, Ultrasound and nuclear imaging), By Application (cardiology, oncology, neurology and others), By End User (Hospitals, Specialty clinics and Diagnostic centres); Size, Share, Development, Growth and Demand Forecast, 2018-2024.

Published: 07/09/2018

Report Code: BWC1820

Available Format: PDF PDF Icon

Pages: 162

Global Vascular Imaging Systems Market: Outlook

Global Vascular Imaging Systems Market report provides analysis for the period 2013–2024, wherein the period from 2018 to 2024 is the forecast period. The market is expected to grow with a CAGR over 5.3% in terms of value. The given market growth is influenced by numerous factors such as increase in the aging population, Increasing prevalence of cardiovascular diseases and cancer, technological advancements in vascular imaging systems, increase in healthcare expenditure etc.

The overall report demonstrates market dynamics such as trends, drivers, restraints, and opportunities influence the current nature and future scenario of the said market.

Global Vascular Imaging Systems Market: Scope of the Report

Based on type of product, the market is segmented into CT, MRI, X-ray, Ultrasound and nuclear imaging. On the basis of application, the market is segmented into cardiology, oncology, and neurology. Based on end user the market is categorised into Hospitals, Specialty clinics, and Diagnostic centers.  Finally, the report covers the analysis of these segments across North America, Europe, Asia Pacific, Middle East, and Africa & Latin America along with the qualitative analysis for market estimates that boosts the growth of the Global Vascular Imaging Systems Market during the forecast period.

The report also highlights the competitive landscape of the Global Vascular Imaging Systems Market that includes the company overview, the products & offerings, Market Share Analysis, strategic decisions taken by the company, launch of new products and financial highlights.

Global Vascular Imaging Systems Market: Key Stakeholders
  • Vascular imaging systems manufacturing companies
  • Suppliers and distributors of MRI, CT, X-ray, ultrasound, PET, and SPECT
  • Healthcare service providers, specialty clinics and diagnostic centres
  • Market research and consulting firms
  • Government bodies/municipal corporations

Global Vascular Imaging Systems, Revenue Forecast, USD (Million) 2018-2024

 

VASCULAR IMAGING SYSTEMS MARKET GRAPH
Source: AGS, AHA, AHEC, ASCI, CDC, CIHI, EANM, IARC, NHS, NIH, OECD, UN-DESA, WHO, Expert Interviews and BlueWeave Consulting Analysis.
Global Vascular Imaging Systems Market: Research Methodology

Extensive secondary research was conducted using paid data sources including Bloomberg, Factiva, Capital IQ, OneSource, and Hoovers. Additionally, several publicly-available data sources were used including journals, statistics articles, and industry associations. These data sources were used to gather relevant information to develop an understanding on the global vascular Imaging Systems market. The research was conducted covering the desk research and primary research. Data sources used for primary research included online forums and blogs, CATI/CAWI, CAPI interviews, and video conferences. Additionally, interviews were conducted through connecting with various industry respondents including C-level executives, directors, divisional heads, regional heads, expert consultants, and independent consultants. The primary research was conducted to gain market insights from industry respondents and validate the gathered information through desk research.

Global Vascular Imaging Systems Market: Research Summary

The Global vascular Imaging Systems Market is growing at a significant rate due to increasing prevalence of cardiovascular diseases and cancer, growth in aging population, widespread increase in the availability of vascular imaging systems, increase in vascular imaging awareness campaigns, technological advancement, and increase in healthcare expenditure.

  • As per the findings of the research, CT has been the largest revenue contributor to the global vascular imaging Systems market as compared to other products contributing over 38.1% in 2017 that is expected to reach over 40.0% by 2024.
  • Based on type, the global nuclear imaging market is categorized into PET and SPECT. This PET segment contributed 60.4% and the SPECT segment contributed over 39.6% to the global market in 2017. The contribution by PET to the market is expected to reach over 63.8% by 2024.
  • Cardiology is the largest application area of this market and is estimated to contribute over 38.0% in 2017. The factors such as number of cardiovascular diseases diagnosed by vascular imaging systems, increase in adoption of vascular imaging equipment owing to increase in awareness campaigns. Oncology segment is expected to contribute over 31.5% in global market during 2024.
  • Hospitals were the largest contributor to the North America vascular imaging systems market in 2017, with the overall share standing at 50.7%. The contribution of end user of vascular imaging systems in hospitals is expected to increase from 50.7% to 51.8% in the anticipated period.
Global Vascular Imaging Systems Market: Competitive Dynamics

Prominent market players of the industry follow certain strategies to gain significant market share such as acquisition & merger, enhancing product portfolio and expanding geographical footprints. The major market players of the industry are Siemens AG, General Electric Company, Hitachi, Ltd, Koninklijke Philips N.V, Carestream Health Inc, Canon Inc, Shimadzu Corporation, Hologic Inc and Esaote S.P.A. Other than these companies there are several small-scale and large –scale industries involve in the market which also hold significant market share.

Chapter 1.  Research Background

1.1    Research Objectives

1.2    Market Definition

1.3     Research Scope

1.3.1     Market segmentation by product

1.3.2     Market segmentation by application

1.3.3      Market segmentation by end user

1.3.4      Market segmentation by geography

1.3.5       Analysis Period

1.3.6       Market Data Reporting Unit

1.3.6.1    Value

1.4     Key Stakeholders

Chapter 2.   Research Methodology

2.1    Secondary Research

2.2    Primary Research

2.2.1    Breakdown of Primary Research Respondents

2.2.1.1   By Region

2.2.1.2   By Industry Participants

2.2.1.3   By Company Type

2.3    Market Size Estimation

2.4    Market Breakdown and Data Triangulation

2.5     Assumptions for the Study

Chapter 3.  Introduction

3.1     Market Segmentation

3.1.1    Overview by product

3.1.1.1     CT

3.1.1.2     MRI

3.1.1.3     X-ray

3.1.1.4     Ultrasound

3.1.1.5     Nuclear imaging

3.1.2    Overview by Application

3.1.2.1     Cardiology

3.1.2.2     Oncology

3.1.2.3     Neurology

3.1.2.4     Others

3.1.3     Overview by End user

3.1.3.1   Hospitals

3.1.3.2  Specialty clinics

3.1.3.3   Diagnostic centers

3.2   Market Dynamics

3.2.1  Trends

3.2.1.1   Increase in number of product launches

3.2.2      Drivers

3.2.2.1   Increasing prevalence of cardiovascular diseases and cancer

3.2.2.2   Growth in aging population

3.2.2.3    Widespread increase in the availability of vascular imaging systems

3.2.2.4    Increase in vascular imaging awareness campaigns

3.2.2.5     Technological advancement in vascular imaging systems

3.2.2.6     Increase in healthcare expenditure

3.2.2.7     Impact analysis of drivers on market forecast

3.2.3    Restraints

3.2.3.1     High cost of vascular imaging systems

3.2.3.2    Stringent regulatory requirements

3.2.3.3    Shortage of helium for magnetic resonance imaging across the  world

3.2.3.4    Increasing risk of cancer due to exposure of radiations

3.2.3.5    Impact analysis of restraints on market forecast

3.2.4     Opportunities

3.2.4.1     Factors such as high demand for vascular imaging systems and development of technologically advanced imaging systems are the growth opportunities for the global vascular imaging systems market.High demand for vascular imaging systems in emerging markets

3.2.4.2     Development of technologically advanced imaging systems

3.2.5    Challenge

3.2.5.1   Dearth of trained healthcare professionals

3.3   Porter’s Five Forces Analysis

3.3.1   Bargaining power of buyers

3.3.2   Bargaining power of suppliers

3.3.3   Threat of new entrants

3.3.4    Intensity of rivalry

3.3.5    Threat of substitutes

Chapter 4.  Market Size and Forecast by product

4.1   Global CT Market

4.1.1   Global CT Market, By Region

4.2   Global MRI Market

4.2.1   Global MRI Market, By Region

4.3   Global X-Ray Market

4.3.1   Global X-Ray Market, By Region

4.4   Global Ultrasound Market

4.4.1  Global Ultrasound Market, By Region

4.5   Global Nuclear Imaging Market

4.5.1  Global Nuclear Imaging Market, By Type

4.5.2   Global Nuclear Imaging Market, By Region

Chapter 5.  Market Size and Forecast by Application

5.1  Global Vascular Imaging Systems Market for Cardiology

5.1.1  Global Vascular Imaging Systems Market for Cardiology, by Region

5.2  Global Vascular Imaging Systems Market for Oncology

5.2.1  Global Vascular Imaging Systems Market for Oncology, by Region

5.3  Global Vascular Imaging Systems Market for Neurology

5.3.1  Global Vascular Imaging Systems Market for Neurology, by Region

5.4   Global Vascular Imaging Systems Market for Others

5.4.1  Global Vascular Imaging Systems Market for Others, by Region

Chapter 6.  Market Size and Forecast by End user

6.1   Global Vascular Imaging Systems Market for Hospitals

6.1.1  Global Vascular Imaging Systems Market for Hospitals, by Region

6.2   Global Vascular Imaging Systems Market for Specialty Clinics

6.2.1  Global Vascular Imaging Systems Market for Specialty Clinics, by Region

6.3   Global Vascular Imaging Systems Market for Diagnostic Centers

6.3.1  Global Vascular Imaging Systems Market for Diagnostic Centres, by Region

Chapter 7.  Market Size and Forecast by Geography

7.1  North America Vascular Imaging Systems Market

7.1.1  North America Vascular Imaging Systems Market,by Product

7.1.2  North America Vascular Imaging Systems Market,by Application

7.1.3  North America Vascular Imaging Systems Market, by End  user

7.1.4  North America Vascular Imaging Systems Market, by  Country

7.2  Europe Vascular Imaging SystemsMarket

7.2.1  Europe Vascular Imaging Systems Market,by Product

7.2.2  Europe Vascular Imaging Systems Market,by Application

7.2.3   Europe Vascular Imaging Systems Market, by End user

7.2.4  Europe Vascular Imaging Systems Market, by Country

7.3   APAC Vascular Imaging Systems Market

7.3.1  APACVascular Imaging Systems Market,by Product

7.3.2   APACVascular Imaging Systems Market,by Application

7.3.3   APAC Vascular Imaging Systems Market, by End user

7.3.4   APAC Vascular Imaging Systems Market, by Country

7.4   Latin America (LATAM)Vascular Imaging Systems Market

7.4.1  LATAMVascular Imaging Systems Market,by Product

7.4.2  LATAM Vascular Imaging Systems Market,by Application

7.4.3   LATAM Vascular Imaging Systems Market, by End user

7.4.4   LATAM Vascular Imaging Systems Market, by Country

7.5  MEA Vascular Imaging Systems Market

7.5.1  MEA Vascular Imaging Systems Market,by Product

7.5.2  MEA Vascular Imaging Systems Market,by Application

7.5.3   MEA Vascular Imaging Systems Market, by End user

Chapter 8.  Competitive Landscape

8.1  Competitive analysis of key players

8.2  Product Benchmarking of Global Vascular Imaging Systems by Key Players

8.3  Market Share Analysis of Global Vascular Imaging Systems Market

8.4  Global Strategic Developments

8.4.1  Product launch

8.4.2  Others

Chapter 9. Company Profiles

9.1   Siemens AG

9.1.1  Business overview

9.1.2   Product and service offerings

9.1.3   Key Financial Summary

9.1.4   Strategic Growth Plans

9.1.5   SWOT Analysis

9.2   General Electric Company

9.2.1  Business overview

9.2.2  Product and service offerings

9.2.3   Key Financial Summary

9.2.4  Strategic Growth Plans

9.2.5   SWOT Analysis

9.3   Hitachi, Ltd.

9.3.1  Business overview

9.3.2  Product and service offerings

9.3.3   Key Financial Summary

9.3.4   Strategic Growth Plans

9.3.5   SWOT Analysis

9.4   Koninklijke Philips N.V.

9.4.1  Business overview

9.4.2  Product and service offerings

9.4.3  Key Financial Summary

9.4.4  Strategic Growth Plans

9.4.5   SWOT Analysis

9.5   Carestream Health, Inc.

9.5.1  Business overview

9.5.2  Product and service offerings

9.5.3  Strategic Growth Plans

9.6  Canon Inc.

9.6.1   Business overview

9.6.2   Product and service offerings

9.6.3   Key Financial Summary

9.6.4   Strategic Growth Plans

9.6.5   SWOT Analysis

9.7   Hologic, Inc.

9.7.1   Business overview

9.7.2   Product and service offerings

9.7.3   Key Financial Summary

9.7.4   Strategic Growth Plans

9.7.5    SWOT Analysis

9.8   Esaote S.p.A

9.8.1  Business overview

9.8.2  Product and service offerings

9.8.3   Strategic Growth Plans

9.9   SHIMADZU CORPORATION

9.9.1  Business overview

9.9.2  Product and service offerings

9.9.3  Key Financial Summary

9.9.4  Strategic Growth Plans

9.10  ORTHOSCAN, INC.

9.10.1  Business overview

9.10.2  Product and service offerings

9.10.3  Strategic Growth Plans

Chapter 10.  Appendix

10.1  Abbreviations

LIST OF TABLES

TABLE 1      ANALYSIS PERIOD OF THE STUDY

TABLE 2     SOME OF THE MAJOR PRODUCT LAUNCHES

TABLE 3     NUMBER OF VASCULAR IMAGING SYSTEMS INSTALLED IN EU MEMBER STATES (2013-2014)

TABLE 4     NUMBER OF VASCULAR IMAGING SYSTEM PROCEDURES, BY COUNTRIES (2014)

TABLE 5     HEALTHCARE EXPENDITURE AS % OF GDP (2013-2014)

TABLE 6     DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 7     COSTS OF VASCULAR IMAGING SYSTEMS

TABLE 8     RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 9     HEALTHCARE EXPENDITURE AS % OF GDP (2013-2014)

TABLE 10    GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 11     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2017 – 2024)

TABLE 12     GLOBAL CT MARKET, BY REGION, $M (2013 – 2016)

TABLE 13     GLOBAL CT MARKET, BY REGION, $M (2017 – 2024)

TABLE 14     GLOBAL MRI MARKET, BY REGION, $M (2013 – 2016)

TABLE 15      GLOBAL MRI MARKET, BY REGION, $M (2017 – 2023)

TABLE 16      RADIATION DOSE ACCORDING TO THE TYPE OF X-RAY PROCEDURES

TABLE 17      GLOBAL X-RAY MARKET, BY REGION, $M (2013 – 2016)

TABLE 18      GLOBAL X-RAY MARKET, BY REGION, $M (2017 – 2023)

TABLE 19      GLOBAL ULTRASOUND MARKET, BY REGION, $M (2013 – 2016)

TABLE 20     GLOBAL ULTRASOUND MARKET, BY REGION, $M (2017 – 2023)

TABLE 21      GLOBAL NUCLEAR IMAGING MARKET, BY TYPE, $M (2013 – 2016)

TABLE 22      GLOBAL NUCLEAR IMAGING MARKET, BY TYPE, $M (2017 – 2024)

TABLE 23      GLOBAL NUCLEAR IMAGING MARKET, BY REGION, $M (2013 – 2016)

TABLE 24      GLOBAL NUCLEAR IMAGING MARKET, BY REGION, $M (2017 – 2024)

TABLE 25      GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 26      GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 27      GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, $M (2013 – 2016)

TABLE 28      GLOBAL VASCULAR IMAGING SYSTEMS FOR MARKET CARDIOLOGY, BY REGION, $M (2017 – 2024)

TABLE 29      GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR ONCOLOGY, BY REGION, $M (2013-2016)

TABLE 30     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR ONCOLOGY, BY REGION, $M (2017-2024)

TABLE 31      GLOBAL VASCULAR IMAGING SYSTEMS FOR NEUROLOGY MARKET, BY REGION, $M (2013-2016)

TABLE 32     GLOBAL VASCULAR IMAGING SYSTEMS FOR NEUROLOGY MARKET, BY REGION, $M(2017-2024)

TABLE 33     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR OTHERS, BY REGION, $M (2013 – 2016)

TABLE 34     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR OTHERS, BY APPLICATION, $M (2017 – 2024)

TABLE 35     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 36     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 37     GLOBAL VASCULAR IMAGING SYSTEMS FOR HOSPITALS MARKET, BY REGION, $M (2013 – 2016)

TABLE 38     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR HOSPITALS, BY REGON, $M (2017 – 2024)

TABLE 39     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR SPECIALTY CLINICS, BY REGION, $M (2013 – 2016)

TABLE 40     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR SPECIALTY CLINICS, BY REGION, $M  (2017 – 2024)

TABLE 41      GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, $M (2013 – 2024)

TABLE 42      GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, $M (2013 – 2016)

TABLE 43      GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, $M (2017 – 2024)

TABLE 44      NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 45      NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2016 – 2024)

TABLE 46      NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 47       NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 48       NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 49       NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 50       NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 51        NORTH AMERICAVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2017 – 2024)

TABLE 52       NUMBER OF IMAGING TESTS(000’S)BY VASCULAR IMAGING SYSTEMS, (2012-2013) AND (2013- 2014)

TABLE 53       EUROPE VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 54       EUROPE VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2017 – 2024)

TABLE 55       EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 56      EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 57      EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 58      EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 59      EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 60      EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2017 – 2024)

TABLE 61       DISTRIBUTION OF VASCULAR IMAGING SYSTEMS IN JAPAN (2008-2011)

TABLE 62       NUMBER OF PROCEDURES OF VASCULAR IMAGING SYSTEMS IN JAPAN (2008-2011)

TABLE 63       TOP ASIA-PACIFIC COUNTRIES IN R&D SPENDING, BY RANKING ($PPP)

TABLE 64       APAC VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 65       APACVASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2017 – 2024)

TABLE 66      APAC VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 67      APACVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 68     APACVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 69     APACVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 70     APACVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 71     APACVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2017 – 2024)

TABLE 72    COST OF MEDICAL TREATMENTS IN BRAZIL COMPARED WITH U.S. HOSPITALS

TABLE 73    LATAM VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 74     LATAMVASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2017 – 2024)

TABLE 75     LATAM VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 76     LATAMVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 77     LATAMVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 78     LATAMVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 79    LATAMVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2016)

TABLE 80    LATAMVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2017 – 2024)

TABLE 81    MEA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2016)

TABLE 82    MEA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2017 – 2024)

TABLE 83    MEA VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2016)

TABLE 84    MEAVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2017 – 2024)

TABLE 85    MEA VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2016)

TABLE 86    MEAVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2017 – 2024)

TABLE 87    SIEMENS AG – AT A GLANCE

TABLE 88    GENERAL ELECTRIC COMPANY – AT A GLANCE

TABLE 89    HITACHI, LTD. – KEY FACTS

TABLE 90    KONINKJILKE PHILIPS N.V. – KEY FACTS

TABLE 91     CARESTREAM HEALTH, INC.– KEY FACTS

TABLE 92    CANON INC. – KEY FACTS

TABLE 93    HOLOGIC, INC. – KEY FACTS

TABLE 94    ESAOTE S.P.A – KEY FACTS

TABLE 95    SHIMADZU CORPORATION – KEY FACTS

TABLE 96    ORTHOSCAN, INC. – KEY FACTS

 

LIST OF FIGURES

FIG 1       RESEARCH SCOPE FOR GLOBAL VASCULAR IMAGING SYSTEMS MARKET

FIG 2       RESEARCH METHODOLOGY FOR VASCULAR IMAGING SYSTEMS MARKET

FIG 3       REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4       BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5       BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6       BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7       DATA TRIANGULATION APPROACH FOR THE GLOBAL VASCULAR IMAGING SYSTEMS MARKET

FIG 8      PREVALENCE OF CORONARY HEART DISEASE BY AGE AND GENDER (FROM 2009-2012)

FIG 9      INCIDENCE RATE OF STROKE BY AGE AND GENDER (2013)

FIG 10     AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 11      AGING POPULATION VS DISEASES, BY COUNTRIES INCOME (2002 AND 2030)

FIG 12     PORTERS FIVE FORCES ANALYSIS FOR GLOBAL VASCULAR IMAGING SYSTEMS MARKET

FIG 13     GLOBAL VASCULAR IMAGING SYSTEMS MARKET SPLIT, BY PRODUCT (2016)

FIG 14     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 15     GLOBAL CT MARKET, BY REGION, $M (2013 – 2024)

FIG 16     WORLDWIDE NUMBER OF MRI INSTALLED, BY TYPE & PERCENTAGE (2010 – 2015)

FIG 17     GLOBAL MRI MARKET, BY REGION, $M (2013 – 2024)

FIG 18     GLOBAL X-RAY MARKET, BY REGION, $M (2013 – 2024)

FIG 19     GLOBAL ULTRASOUND MARKET, BY REGION, $M (2013 – 2024)

FIG 20    NUMBER OF PET CENTERS IN WESTERN EUROPE, BY PERCENTAGE (2010)

FIG 21      GLOBAL NUCLEAR IMAGING MARKET, BY TYPE, $M (2013 – 2024)

FIG 22     GLOBAL NUCLEAR IMAGING MARKET, BY REGION, $M (2013 – 2024)

FIG 23    GLOBAL VASCULAR IMAGING SYSTEMS MARKET SPLIT, BY APPLICATION (2016)

FIG 24    GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 25     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR CARDIOLOGY, BY REGION, $M (2013 – 2024)

FIG 26     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR ONCOLOGY, BY REGION, $M (2013 – 2024)

FIG 27     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR NEUROLOGY, BY REGION, $M (2013–2024)

FIG 28     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR OTHERS, BY REGION, $M (2013 – 2023)

FIG 29     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY END USER (2016)

FIG 30     GLOBAL VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 31     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR HOSPITALS, BY REGION, $M (2013 – 2024)

FIG 32     GLOBAL VASCULAR IMAGING SYSTEMS MARKET FOR SPECIALTY CLINICS, BY REGION, $M (2013 – 2024)

FIG 33     WORLDWIDE MAJOR MARKETS FOR VASCULAR IMAGING SYSTEMS

FIG 34     NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET SNAPSHOT

FIG 35     NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 36    NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 37     NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 38    NORTH AMERICA VASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2024)

FIG 39     EUROPE VASCULAR IMAGING SYSTEMS MARKET SNAPSHOT

FIG 40    EUROPE VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 41     EUROPE VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 42     EUROPEVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 43     EUROPE VASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2024)

FIG 45     APACVASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 46     APACVASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 47     APACVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 48     APACVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2024)

FIG 49      LATAM VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 50     LATAM VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 51      LATAMVASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 52      LATAMVASCULAR IMAGING SYSTEMS MARKET, BY COUNTRY, $M (2013 – 2024)

FIG 54      MEA VASCULAR IMAGING SYSTEMS MARKET, BY PRODUCT, $M (2013 – 2024)

FIG 55      MEA VASCULAR IMAGING SYSTEMS MARKET, BY APPLICATION, $M (2013 – 2024)

FIG 56     MEA VASCULAR IMAGING SYSTEMS MARKET, BY END USER, $M (2013 – 2024)

FIG 57     PRODUCT BENCHMARKING OF GLOBAL VASCULAR IMAGING SYSTEMS BY KEY PLAYERS

FIG 58     GLOBAL VASCULAR IMAGING SYSTEMS MARKET SHARE OF KEY PLAYERS, BY PERCENTAGE (2016)

  1. Research Methodology
Vascular Imaging Systems Market Research Methodology
Source: BlueWeave Consulting Analysis

2.Regional Split of Primary & Secondary Research

Vascular Imaging Systems Market Research Methodology
Source: BlueWeave Consulting Analysis

3.     Secondary Research

The research process began with obtaining historical market sizes of the entire vascular imaging system market and the share of each type of segmentation, through exhaustive secondary research to understand the potential of the market under the prevailing market environment during the past years. The growth rate of the market and its segments was studied with a comparative approach to understand the impact of factors that shaped the market during the recent past.

The next step involved the study of present market environment that is influencing the vascular imaging system market and its expected long-term impact. Weightage was given to several forces that are expected to affect the home security market, during the forecast period. Based on the interim analysis, the market numbers were formulated for each of the forecast years for every segment.

4.       Primary Research

Various industry experts including CEOs, presidents, vice presidents, directors, sales managers, products managers, organization executives and other key people of the global vascular imaging system market were interviewed. The third step involved validation of hypothesis through segmented primary research with the key opinion leaders in the industry, including the company representatives, experts from distributer agencies, service providers and other industry experts. The primary research helped in assessing the gathered and assumed data with the real-time experience of industry representatives. This also led to modification in certain assumptions that were taken during the process of preliminary research. The analysts arrived at solid data points after the completion of primary research process.

In the fourth step, the market engineering was conducted, where the data points collected through secondary and primary sources were compiled to compute the final market sizes

4.1    Breakdown of Primary Research Respondents, By Region

Vascular Imaging Systems Market Research Methodology
Source: BlueWeave Consulting Analysis

           4.2    Breakdown of Primary Research Respondents, By Industry Participants

Vascular Imaging Systems
Source: BlueWeave Consulting Analysis

5.    Market Size Estimation

Top-down approach has been followed to obtain the market size by region, and by country. Bottom-Up approach has been followed to obtain market size by product and by application and by an end user.

An amalgamation of bottom-up and top-down approach has been performed to determine the revenue.

6.       Assumptions for the Study

  • The macro-economic factors would remain same during the forecast period.   
  • The market players would exhibit consistent performance during the forecast period without having any adverse ripple effects on the industry.

Related Posts

Comments (1)

[…] to a new market report published by BlueWeave Consulting (www.blueweaveconsulting.com), the global vascular imaging systems market was valued at US$ 18,217 Mn in 2016 and is expected to expand at a CAGR of 5.31% from 2017 to 2024, […]

Comments are closed.